Balyasny Asset Management LLC Syros Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.69 - $1.21 $10,232 - $17,944	14,830 New	14,830 $14,000
Q2 2018 Aug 14, 2018	SELL	$10.16 - $13.65 $104,648 - $140,595	-10,300 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$9.47 - $12.98 $179,930 - $246,620	-19,000 Reduced 64.85%	10,300 $134,000
Q4 2017 Feb 14, 2018	BUY	$8.45 - $17.48 $247,584 - $512,164	29,300	29,300 $285,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.